This information was published on 2025-08-25T11:28:56 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2577202 (IR 1870074) |
| (220) |
05 May 2025
|
| (300) |
US, 04 Nov 2024, 98834945
|
| (511) (510) |
Class 5
Diagnostic testing kits comprised of medical diagnostic reagents for testing skin cells to identify genetic markers; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in testing neurological and developmental disorders. Class 42 Laboratory research and analysis services in the field of genetics; laboratory analysis for fragile X syndrome, autism, and other genetic conditions; providing medical laboratory services in the field of genetic testing; medical laboratory services for diagnosing genetic disorders; research and development of new products for medical diagnostic monitoring and testing; providing medical and scientific research information via the internet. Class 44 Medical diagnostic testing, monitoring and reporting services; health care services, namely, health assessment services in the nature of behavioral assessment, behavior analysis therapy, medical care, and treatment of behavioral and developmental disorders, including autism, developmental delays, and fragile X syndrome; medical consultation services in the fields of laboratory testing, and diagnostics; genetic testing for medical purposes. |
| (540) | NEUROQURE ASD INSIGHT |
| (550) | Word |
| (730) |
NeuroQure, Inc.
|
Find out more about publications on the About page.